Takano H

No ORCID on file · 4 papers in corpus · active 2015-2023

Study types

  • other 3

Condition tags

  • endometriosis 2
  • adenomyosis 1
other 2023
Gynecology and minimally invasive therapy ·doi:10.4103/gmit.gmit_44_22

OBJECTIVES: Although atypical endometrial hyperplasia (AEH) is considered a precancerous disease, the frequency with which AEH and endometrial cancer (EC) coexist is not low. Broadly, total laparoscopic hysterectomy (TLH) is performed for t…

other 2018
Oncotarget ·doi:10.18632/oncotarget.24555

Ovarian clear cell carcinoma (OCCC) exhibits distinct phenotypes, such as resistance to chemotherapy, poor prognosis and an association with endometriosis. Biomarkers and imaging techniques currently in use are not sufficient for reliable d…

other 2017
Gynecologic oncology ·doi:10.1016/j.ygyno.2017.06.027

OBJECTIVE: Ovarian clear cell carcinoma (OCCC) frequently presents at an early stage. In stage I OCCC, the prognosis differs according to substage. In particular, predictive biomarkers and new treatment strategies are needed for stage IC2/I…

2015
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine ·doi:10.1007/s13277-014-2738-7

Human epididymis protein 4 (HE4) levels and the Risk of Ovarian Malignancy Algorithm (ROMA) have recently been shown to improve the sensitivity and specificity of epithelial ovarian cancer (EOC) diagnosis. We evaluated HE4 levels and ROMA a…